|
Originally published In Press as doi:10.1074/jbc.M110242200 on March 5, 2002
J. Biol. Chem., Vol. 277, Issue 21, 18769-18776, May 24, 2002
Delineation of the Key Amino Acids Involved in Neutrophil
Inhibitory Factor Binding to the I-domain Supports a Mosaic Model for
the Capacity of Integrin M 2 to Recognize
Multiple Ligands*
Valentin A.
Ustinov and
Edward F.
Plow§
From the Joseph J. Jacobs Center for Thrombosis and Vascular
Biology, and Department of Molecular Cardiology/NB50, The Cleveland
Clinic Foundation, Cleveland, Ohio 44195
To gain insight into the mechanism by which the
MI-domain of integrin
M 2 interacts with multiple and unrelated
ligands, the identity of the neutrophil inhibitory factor (NIF)
recognition site was sought. A systematic strategy in which individual
amino acid residues within three previously implicated segments were changed to those in the LI-domain, which is structurally
very similar but does not bind NIF, was implemented. The capacity of the resulting mutants, expressed as glutathione
S-transferase fusion proteins, to recognize NIF was
assessed. These analyses ultimately identified
Asp149, Arg151, Gly207,
Tyr252, and Glu258 as critical for NIF binding.
Cation binding, a function of the metal ion-dependent
adhesion site (MIDAS) motif, was assessed by terbium luminescence to
evaluate conformational perturbations induced by the mutations. All
five mutants bound terbium with unaltered affinities. When the five
residues were inserted into the LI-domain, the chimera
bound NIF with high affinity. Another ligand of
M 2, C3bi, which is known to use the same
segments of the MI-domain in engaging the receptor,
failed to bind to the chimeric LI-domain. Thus, the
MI-domain appears to present a mosaic of exposed amino
acids within surface loops on its MIDAS face, and different ligands
interact with different residues to attain high affinity binding.
*
This work was supported in part by National Institutes of
Health Grant HL 66197.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by an American Heart Association postdoctoral fellowship
from the Northeast Ohio Affiliate.
§
To whom correspondence should be addressed: Joseph J. Jacobs Center
for Thrombosis and Vascular Biology and Dept. of Molecular Cardiology/NB50, The Cleveland Clinic Foundation, 9500 Euclid Ave.,
Cleveland, OH 44195. Tel.: 216-445-8200; Fax: 216-445-8204; E-mail:
plowe@ccf.org.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. A. Soloviev, W. A. Fonzi, R. Sentandreu, E. Pluskota, C. B. Forsyth, S. Yadav, and E. F. Plow
Identification of pH-Regulated Antigen 1 Released from Candida albicans as the Major Ligand for Leukocyte Integrin {alpha}Mbeta2
J. Immunol.,
February 15, 2007;
178(4):
2038 - 2046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-P. Gao, Q. Liu, M. Broman, D. Predescu, R. S. Frey, and A. B. Malik
Inactivation of CD11b in a mouse transgenic model protects against sepsis-induced lung PMN infiltration and vascular injury
Physiol Genomics,
April 14, 2005;
21(2):
230 - 242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Solovjov, E. Pluskota, and E. F. Plow
Distinct Roles for the {alpha} and {beta} Subunits in the Functions of Integrin {alpha}M{beta}2
J. Biol. Chem.,
January 14, 2005;
280(2):
1336 - 1345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. K. Lishko, N. P. Podolnikova, V. P. Yakubenko, S. Yakovlev, L. Medved, S. P. Yadav, and T. P. Ugarova
Multiple Binding Sites in Fibrinogen for Integrin {alpha}M{beta}2 (Mac-1)
J. Biol. Chem.,
October 22, 2004;
279(43):
44897 - 44906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jongstra-Bilen, R. Harrison, and S. Grinstein
Fc{gamma}-receptors Induce Mac-1 (CD11b/CD18) Mobilization and Accumulation in the Phagocytic Cup for Optimal Phagocytosis
J. Biol. Chem.,
November 14, 2003;
278(46):
45720 - 45729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ehlers, V. Ustinov, Z. Chen, X. Zhang, R. Rao, F. W. Luscinskas, J. Lopez, E. Plow, and D. I. Simon
Targeting Platelet-Leukocyte Interactions: Identification of the Integrin Mac-1 Binding Site for the Platelet Counter Receptor Glycoprotein Ib{alpha}
J. Exp. Med.,
October 6, 2003;
198(7):
1077 - 1088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. P. Yakubenko, V. K. Lishko, S. C.-T. Lam, and T. P. Ugarova
A Molecular Basis for Integrin alpha Mbeta 2 Ligand Binding Promiscuity
J. Biol. Chem.,
December 6, 2002;
277(50):
48635 - 48642.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|